Simple blood test could transform inflammatory bowel disease diagnosis

Researchers have identified short-chain fatty acids in blood plasma as potential diagnostic markers for inflammatory bowel disease, a chronic condition affecting millions worldwide. If validated in larger studies, the test could enable faster diagnosis and better disease monitoring, reducing treatment delays and improving patient outcomes while lowering healthcare costs.

Originaltitel: Evaluation of plasma Short chain fatty acid levels as markers for Inflammatory bowel disease